Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera2007 · 196 citations
2. 2The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels2007 · 86 citations
3. 3The JAK2 V617F mutation involves B‐ and T‐lymphocyte lineages in a subgroup of patients with Philadelphia‐chromosome negative chronic myeloproliferative disorders2007 · 162 citations
4. 4Cellular origin and lineage specificity of the JAK2V617F allele in polycythemia vera2007 · 11 citations